Freestone Grove Partners LP purchased a new stake in Cognex Corporation (NASDAQ:CGNX – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 389,605 shares of the scientific and technical instruments company’s stock, valued at approximately $28,215,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in CGNX. Caisse de depot et placement du Quebec acquired a new stake in shares of Cognex during the 2nd quarter worth approximately $2,426,000. Man Group plc acquired a new position in Cognex in the second quarter valued at approximately $3,579,000. Jupiter Topco LLC acquired a new position in Cognex in the second quarter valued at approximately $161,425,000. J. Goldman & Co LP purchased a new position in Cognex in the second quarter worth approximately $16,550,000. Finally, Hsbc Holdings PLC purchased a new position in Cognex in the second quarter worth approximately $2,982,000. Institutional investors and hedge funds own 88.12% of the company’s stock.
Cognex Price Performance
Shares of NASDAQ:CGNX opened at $62.97 on Friday. The firm has a market capitalization of $10.59 billion, a PE ratio of 61.14 and a beta of 1.49. Cognex Corporation has a 1 year low of $34.60 and a 1 year high of $72.88. The firm’s 50-day moving average is $64.54 and its two-hundred day moving average is $59.45.
Cognex Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Thursday, August 20th will be given a $0.085 dividend. This represents a $0.34 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Thursday, August 20th. Cognex’s dividend payout ratio (DPR) is currently 33.01%.
Analysts Set New Price Targets
Several research firms have issued reports on CGNX. UBS Group set a $75.00 target price on Cognex in a research note on Tuesday, May 26th. Barclays reaffirmed an “overweight” rating and issued a $80.00 price target (up from $75.00) on shares of Cognex in a research note on Monday, August 10th. Robert W. Baird set a $72.00 price objective on Cognex in a research report on Friday, May 8th. JPMorgan Chase & Co. upgraded shares of Cognex from a “neutral” rating to an “overweight” rating and boosted their price objective for the company from $65.00 to $75.00 in a report on Tuesday, May 26th. Finally, Sanford C. Bernstein restated an “outperform” rating and issued a $75.00 price objective on shares of Cognex in a report on Thursday, May 7th. Two analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $75.64.
Read Our Latest Report on Cognex
Cognex Profile
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
Featured Stories
- Five stocks we like better than Cognex
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX – Free Report).
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
